Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5177651
Max Phase: Preclinical
Molecular Formula: C18H16N2O4S2
Molecular Weight: 388.47
Associated Items:
ID: ALA5177651
Max Phase: Preclinical
Molecular Formula: C18H16N2O4S2
Molecular Weight: 388.47
Associated Items:
Canonical SMILES: CS(=O)(=O)c1cccc(NC(=O)CNC(=O)c2ccc3sccc3c2)c1
Standard InChI: InChI=1S/C18H16N2O4S2/c1-26(23,24)15-4-2-3-14(10-15)20-17(21)11-19-18(22)13-5-6-16-12(9-13)7-8-25-16/h2-10H,11H2,1H3,(H,19,22)(H,20,21)
Standard InChI Key: MAWAKAULEYRAFQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 388.47 | Molecular Weight (Monoisotopic): 388.0551 | AlogP: 2.67 | #Rotatable Bonds: 5 |
Polar Surface Area: 92.34 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.98 | CX Basic pKa: | CX LogP: 1.68 | CX LogD: 1.68 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.70 | Np Likeness Score: -2.36 |
1. Sánchez-Morales A, Biçer A, Panagiotopoulos V, Crecente-Garcia S, Benaiges C, Bayod S, Luís Hernández J, Busqué F, Matsoukas MT, Pérez-Riba M, Alibés R.. (2022) Design and synthesis of a novel non peptide CN-NFATc signaling inhibitor for tumor suppression in triple negative breast cancer., 238 [PMID:35700596] [10.1016/j.ejmech.2022.114514] |
Source(1):